Live from JPM 2026, a sit-down with Novo Nordisk’s CEO and VC Bob Nelsen

Live from JPM 2026, a sit-down with Novo Nordisk’s CEO and VC Bob Nelsen










How did an office clerk become CEO of a major pharmaceutical company? What’s “Project Prometheus”? And what’s next in drug R&D?

Allison, Adam, and Elaine are asking those questions live from the J.P. Morgan Healthcare Conference in San Francisco.

Read the rest…






Allison DeAngelis, Adam Feuerstein, and Elaine Chen





Go to statnews